A double blind randomized psychoactive placebo-controlled, study to evaluate the efficacy and safety of 3 fixed doses (28mg, 56mg and 84 mg) of intranasal esketamine in addition to comprehensive standard of care for the rapid reduction of the sympoms of major depressive disorder, including suicidal ideation, in pediatric subjects assessed to be at imminent risk of suicide
A multi-centre, randomised controlled study, to evaluate the safety and performance of The dialive liver dialysis device (LDD) in patients with acute on chronic liver failure (ACLF) versus standard of care (SOC)
A prospective, multi-center, double-blind, randomized, placebo-controlled, parallel-group, Phase 3 study to assess the efficacy and safety of clazosentan in preventing clinical deterioration due to delayed cerebral ischemia (DCI), in adult subjects with aneurysmal subarachnoid hemorrhage (aSAH)
Captesia™, une nouvelle application pour Android™ permettant le calcul de la variation de la pression pulsée (VPP) et du débit cardiaque (DC) : comparaison avec la VPP et le DC obtenu par une méthode de thermodilution transpulmonaire aux soins intensifs
A double - blind, randomized, placebo-controlled clinical study of the efficacy of intravenous clarithromycin as adjunctive treatment in patients with sepsis and respiratory and multiple organ dysfunction syndrome
Effect of high-dose vitamin D3 on 28-day mortality in adult critically ill patients with severe vitamin D deficiency: a multicenter, placebo-controlled double-blind phase III RCT
Prospective, randomized, open, controlled, multicenter study to evaluate the safety and efficacy of the MON4STRAT approach for optimizing meropenem therapy in intubated and mechanically-ventilated, adult patients with gram-negative lower respiratory tract infection including nosocomial pneumonia and severe tracheobronchitis MON4STRAT study
A multicenter, randomized, double-blind, parallel- group, clinical study of s-649266 compared with meropenem for the treatment of hospital-acquired bacterial pneumonia,ventilator-associated bacterial pneumonia, or healthcare-associated bacterial pneumonia caused by gram-negative pathogens